BCM
MURA

Bridgeway Capital Management’s Mural Oncology MURA Stock Holding History

Bridgeway Capital Management’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115,872
Closed -$146K – 1228
2025
Q1 		$146K Buy
115,872
+86,572
+295% +$316K ﹤0.01% 980
2024
Q4 		$94.3K Buy
+29,300
New +$103K ﹤0.01% 1117

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bridgeway Capital Management's MURA Position: Q2 2025 in Review

Bridgeway Capital Management sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 115,872 shares — an estimated $146K sold.

Bridgeway Capital Management first reported a position in MURA in Q4 2024 and held it in 2 quarters. The position peaked at $146K in Q1 2025. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Bridgeway Capital Management reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 115,872 Mural Oncology shares in Q2 2025, an estimated $146K.
  • Bridgeway Capital Management first reported a position in Mural Oncology in Q4 2024 and held it in 2 quarters.
  • Bridgeway Capital Management's Mural Oncology position peaked at $146K in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.